Anbio Biotechnology (NASDAQ:NNNN) Trading 6.8% Higher – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) was up 6.8% on Wednesday . The company traded as high as $12.68 and last traded at $12.50. Approximately 3,397 shares were traded during trading, a decline of 92% from the average session volume of 44,826 shares. The stock had previously closed at $11.70.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold”.

Anbio Biotechnology Trading Down 3.0%

The stock’s 50 day moving average is $22.17.

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.